Total Payments
$8,104
2024 Payments
$3,082
Companies
37
Transactions
333
Medicare Patients
3,867
Medicare Billing
$420,257
Payment Breakdown by Category
Food & Beverage$8,090 (99.8%)
Education$13.89 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,090 | 332 | 99.8% |
| Education | $13.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $1,328 | 19 | $0 (2024) |
| Esperion Therapeutics, Inc. | $656.72 | 51 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $561.64 | 6 | $0 (2024) |
| Boston Scientific Corporation | $516.06 | 10 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $414.87 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $388.61 | 34 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $384.07 | 20 | $0 (2024) |
| Edwards Lifesciences Corporation | $368.00 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $363.43 | 27 | $0 (2024) |
| CVRx, Inc. | $328.39 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,082 | 114 | BIOTRONIK INC. ($472.17) |
| 2023 | $2,898 | 120 | BIOTRONIK INC. ($420.87) |
| 2022 | $2,022 | 93 | BIOTRONIK INC. ($434.87) |
| 2021 | $85.04 | 5 | Merck Sharp & Dohme Corporation ($22.54) |
| 2018 | $18.47 | 1 | Medtronic Vascular, Inc. ($18.47) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $36.87 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/25/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Genetic Disease | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Not Applicable | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.42 | General |
| Category: Endovascular | ||||||
| 10/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $157.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: Transcatheter Heart Valves | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,945 | 2,526 | $682,995 | $201,617 |
| 2022 | 19 | 1,751 | 2,207 | $614,118 | $202,101 |
| 2021 | 8 | 171 | 173 | $57,242 | $16,539 |
Total Patients
3,867
Total Services
4,906
Medicare Billing
$420,257
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 484 | 497 | $288,260 | $64,933 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 327 | $75,210 | $28,808 | 38.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 80 | 80 | $71,760 | $25,668 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 142 | 142 | $34,222 | $16,006 | 46.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 80 | 160 | $23,469 | $14,540 | 62.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 72 | 288 | $23,184 | $11,997 | 51.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 62 | 64 | $30,720 | $10,323 | 33.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 117 | 118 | $29,500 | $5,357 | 18.2% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 51 | 58 | $11,310 | $3,618 | 32.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 81 | 82 | $24,600 | $3,616 | 14.7% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 19 | 19 | $7,275 | $3,559 | 48.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 291 | 340 | $17,000 | $3,380 | 19.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 59 | 61 | $10,980 | $2,352 | 21.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 18 | 18 | $6,858 | $2,345 | 34.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 21 | 40 | $12,000 | $1,949 | 16.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 59 | 61 | $8,540 | $1,086 | 12.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 14 | 34 | $2,550 | $729.28 | 28.6% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 19 | 29 | $2,175 | $497.75 | 22.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 12 | 73 | $2,190 | $412.19 | 18.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 18 | $810.00 | $317.16 | 39.2% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 17 | 17 | $382.50 | $124.29 | 32.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 444 | 451 | $261,580 | $63,799 | 24.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 73 | 74 | $66,283 | $25,284 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 161 | 161 | $38,801 | $19,861 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 197 | $43,285 | $19,157 | 44.3% |
About Jeevan Kumar
Jeevan Kumar is a Internal Medicine healthcare provider based in Amherst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2015. The National Provider Identifier (NPI) number assigned to this provider is 1366820078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeevan Kumar has received a total of $8,104 in payments from pharmaceutical and medical device companies, with $3,082 received in 2024. These payments were reported across 333 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,090).
As a Medicare-enrolled provider, Kumar has provided services to 3,867 Medicare beneficiaries, totaling 4,906 services with total Medicare billing of $420,257. Data is available for 3 years (2021–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Amherst, NY
- Active Since 05/13/2015
- Last Updated 08/23/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366820078
Products in Payments
- LifeVest (Device) $414.87
- Arcalyst (Drug) $384.07
- Edora 8 DR-T (Device) $368.06
- NEXLETOL (Drug) $360.24
- OPTIMIZER (Device) $354.30
- Barostim Neo System (Device) $328.39
- NEXLIZET (Drug) $296.48
- AMVIA EDGE (Device) $271.47
- Rivacor 7 DR-T (Device) $258.54
- ELIQUIS (Drug) $248.00
- WATCHMAN FLX (Device) $240.28
- Acticor 7 VR-T DX (Device) $229.60
- LEQVIO (Drug) $225.15
- JARDIANCE (Drug) $217.30
- Optimizer (Device) $207.34
- ONPATTRO (Drug) $205.00
- WATCHMAN Access System (Device) $201.24
- BIOMONITOR (Device) $200.24
- Repatha (Biological) $196.89
- VERQUVO (Drug) $195.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Amherst
Dr. George Bescak, D.o, D.O
Internal Medicine — Payments: $16,900
Internal Medicine $16,900
Edgardo Salvador, Md, MD
Internal Medicine — Payments: $11,533
Internal Medicine $11,533
Dr. Lester Sielski, M.d, M.D
Internal Medicine — Payments: $9,602
Internal Medicine $9,602
Dr. Joseph Gentile, Md, MD
Internal Medicine — Payments: $6,477
Internal Medicine $6,477
Dawn Harbatkin, Md, MD
Internal Medicine — Payments: $5,858
Internal Medicine $5,858
Dr. Thomas Cimato, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $2,798
Internal Medicine $2,798